|
|
|
| Webinar: Sustainable vaccine manufacturing: securing the future of global health | Join Cytiva for a webinar on the future of vaccine manufacturing, highlighting next-gen technologies, mRNA platforms, and digital tools that boost efficiency, cut costs, and expand access. Learn practical strategies to optimize processes, streamline tech transfer, and enable distributed manufacturing—equipping you to build more resilient, flexible, and sustainable production systems. Click here to learn more. |
|
|
|
|
By AR Welch, Editorial & Community Director, Advancing RNA | In my presentation, I argued that there are several lessons we can learn from Picasso that will also help our own industry mature. In the upcoming weeks, I plan to unpack these lessons, highlighting specific instances in which I see our industry taking these lessons to heart and making progress — starting here with lesson 1: Being Innovative Comes After We Master The Basics | |
|
|
|
By Marcelo Trevino, independent expert | Recent shifts within the U.S. FDA reflect an increasingly complex tension between scientific rigor and accelerating political and economic pressures. Here are the newest developments and emerging focal points. | |
|
|
|
Panelists Tiffany Lucas and Ulrike Jägle address an audience question about when and how to approach the regulatory agencies for mRNA process development. In addition to listing the different FDA and EMA meeting opportunities available to sponsors, Jägle reminds us of one critical best practices sponsors shouldn’t forget when approaching the agencies. |
|
|
|
|
| Exploring RNA Structure And Ligand Interactions With MMS | Video | RedShiftBio | Learn about using microfluidic modulation spectroscopy (MMS) to probe RNA base pair and ligand interactions in solution. This research explores the effects of lipid adducts on RNA structure and characterizes base pairing with MMS. |
|
|
|
|
|
|
|
| Advanced Isolator Tech Boosts Manufacturing Efficiency And Quality | Article | By Gregory Benzel and Michael Jack, Jubilant HollisterStier | Isolator technology can run continuously over several days, minimizing operator interaction and other opportunities to introduce contamination — ideal for high-volume, time-limited production runs. |
|
|
| A New Centre For Continuous mRNA Manufacturing | Article | ReciBioPharm | Explore how a partnership between academia, regulatory agencies, and manufacturing organizations has the potential to reshape the way we produce and distribute mRNA-based therapies. |
|
|
.png){kind=logo}
